Literature DB >> 8253083

Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA.

R Andino1, G E Rieckhof, P L Achacoso, D Baltimore.   

Abstract

The structure of a ribonucleoprotein complex formed at the 5'-end of poliovirus RNA was investigated. This complex involves the first 90 nucleotides of poliovirus genome which fold into a cloverleaf-like structure and interact with both uncleaved 3CD, the viral protease-polymerase precursor, and a 36 kDa ribosome-associated cellular protein. The cellular protein is required for complex formation and interacts with unpaired bases in one stem-loop of the cloverleaf RNA. Amino acids within the 3C protease which are important for RNA binding were identified by site-directed mutagenesis and the crystal structure of a related protease was used to model the RNA binding domain within the viral 3CD protein. The physiologic importance of the ribonucleic-protein complex is suggested by the finding that mutations that disrupt complex formation abolish RNA replication but do not affect RNA translation or stability. Based on these structural and functional findings we propose a model for the initiation of poliovirus RNA synthesis where an initiation complex consisting of 3CD, a cellular protein, and the 5'-end of the positive strand RNA catalyzes in trans the initiation of synthesis of new positive stranded RNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253083      PMCID: PMC413634          DOI: 10.1002/j.1460-2075.1993.tb06032.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

Review 1.  Cysteine proteases of positive strand RNA viruses and chymotrypsin-like serine proteases. A distinct protein superfamily with a common structural fold.

Authors:  A E Gorbalenya; A P Donchenko; V M Blinov; E V Koonin
Journal:  FEBS Lett       Date:  1989-01-30       Impact factor: 4.124

Review 2.  Regulation of translation by poliovirus.

Authors:  N Sonenberg
Journal:  Adv Virus Res       Date:  1987       Impact factor: 9.937

3.  Genetic complementation among poliovirus mutants derived from an infectious cDNA clone.

Authors:  H D Bernstein; P Sarnow; D Baltimore
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

4.  Deletion analysis of the capsid protein of Sindbis virus: identification of the RNA binding region.

Authors:  U Geigenmüller-Gnirke; H Nitschko; S Schlesinger
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

5.  Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus.

Authors:  T Takegami; R J Kuhn; C W Anderson; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Genome-linked proteins of viruses.

Authors:  E Wimmer
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

7.  Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach.

Authors:  H Toyoda; C F Yang; N Takeda; A Nomoto; E Wimmer
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

8.  Poliovirus mutant that does not selectively inhibit host cell protein synthesis.

Authors:  H D Bernstein; N Sonenberg; D Baltimore
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

9.  High efficiency polyoma DNA transfection of chloroquine treated cells.

Authors:  H Luthman; G Magnusson
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more
  263 in total

1.  A cysteine-rich motif in poliovirus protein 2C(ATPase) is involved in RNA replication and binds zinc in vitro.

Authors:  T Pfister; K W Jones; E Wimmer
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis.

Authors:  D J Barton; B J O'Donnell; J B Flanegan
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

3.  Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.

Authors:  D A Matthews; P S Dragovich; S E Webber; S A Fuhrman; A K Patick; L S Zalman; T F Hendrickson; R A Love; T J Prins; J T Marakovits; R Zhou; J Tikhe; C E Ford; J W Meador; R A Ferre; E L Brown; S L Binford; M A Brothers; D M DeLisle; S T Worland
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis.

Authors:  J Herold; R Andino
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Identification of a cis-acting replication element within the poliovirus coding region.

Authors:  I Goodfellow; Y Chaudhry; A Richardson; J Meredith; J W Almond; W Barclay; D J Evans
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Specific HDV RNA-templated transcription by pol II in vitro.

Authors:  J Filipovska; M M Konarska
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

7.  Interactions of viral protein 3CD and poly(rC) binding protein with the 5' untranslated region of the poliovirus genome.

Authors:  A V Gamarnik; R Andino
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Phenotypic characterization of three phylogenetically conserved stem-loop motifs in the mengovirus 3' untranslated region.

Authors:  H Duque; A C Palmenberg
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

9.  Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg.

Authors:  A V Paul; E Rieder; D W Kim; J H van Boom; E Wimmer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

10.  Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation.

Authors:  E Rieder; A V Paul; D W Kim; J H van Boom; E Wimmer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.